NCT02488850View on ClinicalTrials.gov

Determination of Peripheral Immune Cell Activity During Treatment With Either Surgery or Radiotherapy in Patients With Early Stage NSCLC

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

April 5, 2022

Study Completion Date

April 5, 2022

Conditions
Non-small Cell Lung Cancer
Interventions
PROCEDURE

Surgery

RADIATION

SABR

Trial Locations (3)

3015GD

Erasmus MC Cancer Institute, Rotterdam

Unknown

Antoni van Leeuwenhoek Hospital, Amsterdam

VU Medical Center, Amsterdam

Sponsors
All Listed Sponsors
lead

Erasmus Medical Center

OTHER